These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 22354875)
21. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells. Stettner MR; Wang W; Nabors LB; Bharara S; Flynn DC; Grammer JR; Gillespie GY; Gladson CL Cancer Res; 2005 Jul; 65(13):5535-43. PubMed ID: 15994925 [TBL] [Abstract][Full Text] [Related]
22. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867 [TBL] [Abstract][Full Text] [Related]
23. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544 [TBL] [Abstract][Full Text] [Related]
24. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer. Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227 [TBL] [Abstract][Full Text] [Related]
25. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192 [TBL] [Abstract][Full Text] [Related]
26. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation. Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672 [TBL] [Abstract][Full Text] [Related]
27. Src family kinases differentially influence glioma growth and motility. Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207 [TBL] [Abstract][Full Text] [Related]
28. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets. Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238 [TBL] [Abstract][Full Text] [Related]
29. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Newsome TP; Weisswange I; Frischknecht F; Way M Cell Microbiol; 2006 Feb; 8(2):233-41. PubMed ID: 16441434 [TBL] [Abstract][Full Text] [Related]
30. Cyclic stretch induces reorientation of cells in a Src family kinase- and p130Cas-dependent manner. Niediek V; Born S; Hampe N; Kirchgessner N; Merkel R; Hoffmann B Eur J Cell Biol; 2012 Feb; 91(2):118-28. PubMed ID: 22178114 [TBL] [Abstract][Full Text] [Related]
31. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377 [TBL] [Abstract][Full Text] [Related]
32. Activation of the lutropin/choriogonadotropin receptor in MA-10 cells leads to the tyrosine phosphorylation of the focal adhesion kinase by a pathway that involves Src family kinases. Mizutani T; Shiraishi K; Welsh T; Ascoli M Mol Endocrinol; 2006 Mar; 20(3):619-30. PubMed ID: 16293639 [TBL] [Abstract][Full Text] [Related]
33. Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. Hirsch CL; Smith-Windsor EL; Bonham K Int J Cancer; 2006 Feb; 118(3):547-54. PubMed ID: 16094635 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of Src impairs the growth of met-addicted gastric tumors. Bertotti A; Bracco C; Girolami F; Torti D; Gastaldi S; Galimi F; Medico E; Elvin P; Comoglio PM; Trusolino L Clin Cancer Res; 2010 Aug; 16(15):3933-43. PubMed ID: 20628031 [TBL] [Abstract][Full Text] [Related]
35. Regulation of peripheral myelination by Src-like kinases. Hossain S; Fragoso G; Mushynski WE; Almazan G Exp Neurol; 2010 Nov; 226(1):47-57. PubMed ID: 20696161 [TBL] [Abstract][Full Text] [Related]
36. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Yadav V; Denning MF Mol Carcinog; 2011 May; 50(5):346-52. PubMed ID: 21480388 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors. Dincer S; Cetin KT; Onay-Besikci A; Ölgen S J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1080-7. PubMed ID: 22957720 [TBL] [Abstract][Full Text] [Related]
38. Purinergic agonists stimulate lens Na-K-ATPase-mediated transport via a Src tyrosine kinase-dependent pathway. Tamiya S; Okafor MC; Delamere NA Am J Physiol Cell Physiol; 2007 Aug; 293(2):C790-6. PubMed ID: 17522142 [TBL] [Abstract][Full Text] [Related]
39. TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. Liu A; Gong P; Hyun SW; Wang KZ; Cates EA; Perkins D; Bannerman DD; Puché AC; Toshchakov VY; Fang S; Auron PE; Vogel SN; Goldblum SE J Biol Chem; 2012 May; 287(20):16132-45. PubMed ID: 22447928 [TBL] [Abstract][Full Text] [Related]
40. Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Yamaji M; Ota A; Wahiduzzaman M; Karnan S; Hyodo T; Konishi H; Tsuzuki S; Hosokawa Y; Haniuda M Cancer Med; 2017 Nov; 6(11):2646-2659. PubMed ID: 28960945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]